Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider Sells $1,310,218.56 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider Kendall Forbes sold 64,991 shares of Guardian Pharmacy Services stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total value of $1,310,218.56. Following the sale, the insider now directly owns 203,906 shares of the company's stock, valued at approximately $4,110,744.96. This represents a 24.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Kendall Forbes also recently made the following trade(s):

• On Tuesday, May 27th, Kendall Forbes sold 350,058 shares of Guardian Pharmacy Services stock. The stock was sold at an average price of $20.16, for a total value of $7,057,169.28.

Guardian Pharmacy Services Stock Performance

Shares of GRDN stock traded down $0.10 on Friday, hitting $21.29. The company had a trading volume of 481,223 shares, compared to its average volume of 168,263. Guardian Pharmacy Services, Inc. has a twelve month low of $14.16 and a twelve month high of $26.91. The company has a 50-day moving average price of $23.16 and a 200-day moving average price of $22.00.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to the consensus estimate of $321.21 million. On average, equities analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on GRDN shares. Raymond James set a $28.00 price objective on Guardian Pharmacy Services and gave the company an "outperform" rating in a report on Wednesday, May 14th. Truist Financial reissued a "buy" rating and issued a $28.00 price objective (up previously from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Finally, Wall Street Zen cut Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of hedge funds have recently made changes to their positions in GRDN. R Squared Ltd purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at approximately $30,000. Calamos Advisors LLC grew its position in Guardian Pharmacy Services by 124.7% in the fourth quarter. Calamos Advisors LLC now owns 24,725 shares of the company's stock worth $501,000 after acquiring an additional 13,720 shares during the period. Compass Financial Services Inc purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $58,000. Rhumbline Advisers purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $149,000. Finally, New York State Common Retirement Fund boosted its position in shares of Guardian Pharmacy Services by 17.9% during the fourth quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock worth $5,643,000 after buying an additional 42,368 shares during the period.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.